Pharma Equity Group consolidated Interim Report 1 January – 30 June 2026

Barchart · 2d ago

Consolidated Interim Report 1 January – 30 June 2026
14 August 2025
Announcement no. 9

On 14 August 2026, the Board of Directors and the Executive Board of Pharma Equity Group A/S ("PEG", "The Company" or the "Group") considered and approved the interim report for the Group for the period 1 January – 30 June 2026 ("H1 2026 report"), which can be summarized as follows:

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.